Insulin Glargine
NDC 83257-015, insulin Glargine-yfgn, injection, solution, from Biocon Biologics Inc..
- Product NDC
- 83257-015
- Status
- Listed
- Labeler
- Biocon Biologics Inc.
- Dosage form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA761201
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/83257-015 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- INSULIN GLARGINE100 [iU]/mL
Pharmacologic classes
Insulin Analog [EPC]; Insulin [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 83257-015-31 | 83257001531 | 1 SYRINGE in 1 CARTON (83257-015-31) / 3 mL in 1 SYRINGE |
| 83257-015-32 | 83257001532 | 5 SYRINGE in 1 CARTON (83257-015-32) / 3 mL in 1 SYRINGE |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/3ac85ebb-5594-59c8-77fd-df254329d151NADAC price for package 83257001532
GET /v1/drugs/nadac/83257001532
Use it
Look up 83257-015 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/83257-015 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 83257-015. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.